Skip to content
Insider tapeFilings through Fri, Nov 13
My stocks

Richard Blumenthal: stock trades

Senator. 12 reported trades in 1 stock.

TradedStockTradeReportedSince tradeSince publicS&P 500
Sep 23, 2026 STLNStarling Oncology, Inc. - Common Stock Sold$1,001 - $15,000 · spouse Oct 26, 2026 Report -48.7% -44.4% -1.4%
Sep 23, 2026 STLNStarling Oncology, Inc. - Common Stock Sold$1,001 - $15,000 · spouse Oct 26, 2026 Report -48.7% -44.4% -1.4%
Sep 22, 2026 STLNStarling Oncology, Inc. - Common Stock Sold$1,001 - $15,000 · spouse Oct 26, 2026 Report -50.4% -44.4% -1.4%
Sep 22, 2026 STLNStarling Oncology, Inc. - Common Stock Sold$15,001 - $50,000 · spouse Oct 26, 2026 Report -50.4% -44.4% -1.4%
Sep 22, 2026 STLNStarling Oncology, Inc. - Common Stock Sold$15,001 - $50,000 · spouse Oct 26, 2026 Report -50.4% -44.4% -1.4%
Sep 22, 2026 STLNStarling Oncology, Inc. - Common Stock Sold$1,001 - $15,000 · spouse Oct 26, 2026 Report -50.4% -44.4% -1.4%
Sep 22, 2026 STLNStarling Oncology, Inc. - Common Stock Sold$15,001 - $50,000 · spouse Oct 26, 2026 Report -50.4% -44.4% -1.4%
Sep 18, 2026 STLNStarling Oncology, Inc. - Common Stock Sold$1,001 - $15,000 · spouse Oct 26, 2026 Report -49.7% -44.4% -1.4%
Sep 18, 2026 STLNStarling Oncology, Inc. - Common Stock Sold$15,001 - $50,000 · spouse Oct 26, 2026 Report -49.7% -44.4% -1.4%
Sep 18, 2026 STLNStarling Oncology, Inc. - Common Stock Sold$15,001 - $50,000 · spouse Oct 26, 2026 Report -49.7% -44.4% -1.4%
Sep 18, 2026 STLNStarling Oncology, Inc. - Common Stock Sold$1,001 - $15,000 · spouse Oct 26, 2026 Report -49.7% -44.4% -1.4%
Sep 18, 2026 STLNStarling Oncology, Inc. - Common Stock Sold$15,001 - $50,000 · spouse Oct 26, 2026 Report -49.7% -44.4% -1.4%

Returns are only shown for stocks we track. Amounts are the ranges given in the report. Facts as reported, without commentary; nothing here suggests wrongdoing.

Follow Richard Blumenthal

Get one email when Richard Blumenthal reports a new stock trade. Free.

At most one email a day about Richard Blumenthal, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.

Information from public STOCK Act disclosure reports, shared free with the public. Not investment advice.